Imexpharm Corporation Stock

Equities

IMP

VN000000IMP0

Pharmaceuticals

End-of-day quote Ho Chi Minh S.E. 06:00:00 2024-04-18 pm EDT 5-day change 1st Jan Change
69,300 VND -2.39% Intraday chart for Imexpharm Corporation +2.51% +22.44%
Sales 2024 * 2,190B 85.41M Sales 2025 * - Capitalization 4,851B 189M
Net income 2024 * 340B 13.24M Net income 2025 * - EV / Sales 2024 * 2.24 x
Net Debt 2024 * 57B 2.22M Net cash position 2025 * - 0 EV / Sales 2025 * -
P/E ratio 2024 *
14.3 x
P/E ratio 2025 *
-
Employees 1,415
Yield 2024 *
-
Yield 2025 *
-
Free-Float 11.52%
More Fundamentals * Assessed data
Dynamic Chart
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Imexpharm Corporation Approves Election of Hoang Duc Hung as an Independent Member of the Board of Directors CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Imexpharm Corporation Announces Dividend, Payable on October 20, 2023 CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Imexpharm Corporation Appoints Chun Chaerhan as Chairperson of the Board of Directors CI
Imexpharm Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Imexpharm Corporation Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Imexpharm Corporation Reports Earnings Results for the Fourth Quarter Ended December 31, 2022 CI
Imexpharm Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Imexpharm Corporation announced that it has received funding from SK Group Ltd. CI
Imexpharm Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Imexpharm Corporation Announces Personnel Change CI
Imexpharm Corporation Announces Cash Dividend for 2021, Payable on June 24, 2022 CI
More news
1 day-2.39%
1 week+2.51%
Current month+0.87%
1 month+5.16%
3 months+8.62%
6 months+11.77%
Current year+22.44%
More quotes
1 week
68 400.00
Extreme 68400
71 400.00
1 month
66 500.00
Extreme 66500
71 400.00
Current year
56 500.00
Extreme 56500
71 400.00
1 year
48 095.24
Extreme 48095.2381
71 428.57
3 years
41 428.57
Extreme 41428.5714
82 285.71
5 years
28 681.32
Extreme 28681.3187
82 285.71
10 years
18 532.19
Extreme 18532.1924
82 285.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 71 83-12-31
Chairman 61 98-12-31
Director/Board Member 45 03-12-31
Members of the board TitleAgeSince
Chief Executive Officer 71 83-12-31
Chairman 61 98-12-31
Director/Board Member 44 16-12-31
More insiders
Date Price Change Volume
24-04-18 69,300 -2.39% 17 600
24-04-17 71,000 +2.45% 48,500
24-04-16 69,300 -0.14% 35,800
24-04-15 69,400 -1.28% 48,400
24-04-12 70,300 +3.99% 71,200

End-of-day quote Ho Chi Minh S.E., April 18, 2024

More quotes
Imexpharm Corporation is a Vietnam-based company engaged in the pharmaceutical industry. The Company manufactures, imports, exports and trades pharmaceutical products, antiseptics, traditional medicine, medical equipment and supplies, cosmetics, supplemental food and drinks. It is also involved in the provision of packaging services and warehousing services for pharmaceutical storage purposes. In addition, the Company is involved in medicinal herb cultivation.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
69,300 VND
Average target price
77,033 VND
Spread / Average Target
+11.16%
Consensus

Annual profits - Rate of surprise